Trademark: 85773902
Word
ACTAVIS
Status
Dead
Status Code
606
Status Date
Monday, February 12, 2018
Serial Number
85773902
Mark Type
3000
Filing Date
Wednesday, November 7, 2012
Published for Opposition
Tuesday, August 6, 2013
Abandoned Date
Monday, February 12, 2018

Trademark Owner History
ACTAVIS HOLDCO US, INC. - 1st New Owner After Publication
ACTAVIS, INC. - Owner At Publication
Actavis Group PTC ehf - Original Applicant

Classifications
1 Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals, chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industry
3 Soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care, cosmetic skin fresheners and toners, cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teeth
5 Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; contraceptives; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations, pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels, pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activators
41 Education services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, women's health, pharmaceuticals and medicine, pharmaceutical research and development
42 Scientific and technological services, namely, consulting in the field of pharmaceuticals pertaining to biotechnology, product evaluation, diagnostics, testing and inspection; pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysis
The color(s) green and blue is/are claimed as a feature of the mark.
The mark consists of the word "ACTAVIS" displayed in the color green, below the letters "a" and "w", which appear in an intertwined, fanciful lettering style displayed in the colors green and blue that resembles a horizontal zig-zag line or a coil.

Trademark Events
Feb 12, 2018
Abandonment Notice Mailed - No Use Statement Filed
Feb 12, 2018
Abandonment - No Use Statement Filed
Jul 27, 2017
Notice Of Approval Of Extension Request E-Mailed
Jul 26, 2017
Extension 4 Granted
Jul 7, 2017
Extension 4 Filed
Jul 20, 2017
Notice Of Revival - E-Mailed
Jul 19, 2017
Extension Received With Teas Petition
Jul 19, 2017
Petition To Revive-Granted
Jul 19, 2017
Teas Petition To Revive Received
Jul 19, 2017
Teas Change Of Correspondence Received
Feb 22, 2017
Automatic Update Of Assignment Of Ownership
Jan 6, 2017
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2017
Extension 3 Granted
Jan 4, 2017
Extension 3 Filed
Jan 4, 2017
Teas Extension Received
Aug 2, 2016
Notice Of Approval Of Extension Request E-Mailed
Aug 1, 2016
Extension 2 Granted
Jun 28, 2016
Extension 2 Filed
Jul 29, 2016
Case Assigned To Intent To Use Paralegal
Jun 28, 2016
Teas Extension Received
Nov 25, 2015
Notice Of Approval Of Extension Request E-Mailed
Nov 23, 2015
Extension 1 Granted
Nov 23, 2015
Extension 1 Filed
Nov 23, 2015
Teas Extension Received
Jul 7, 2015
Noa E-Mailed - Sou Required From Applicant
Feb 10, 2015
Ttab Release Case To Trademarks
Feb 10, 2015
Opposition Terminated No. 999999
Feb 10, 2015
Opposition Dismissed No. 999999
Jan 30, 2014
Opposition Instituted No. 999999
Aug 16, 2013
Extension Of Time To Oppose Received
Aug 6, 2013
Official Gazette Publication Confirmation E-Mailed
Aug 6, 2013
Published For Opposition
Jul 17, 2013
Notification Of Notice Of Publication E-Mailed
Jul 3, 2013
Law Office Publication Review Completed
Jul 2, 2013
Assigned To Lie
Jul 1, 2013
Assigned To Examiner
Jun 14, 2013
Approved For Pub - Principal Register
Jun 13, 2013
Teas/Email Correspondence Entered
Jun 13, 2013
Correspondence Received In Law Office
Jun 13, 2013
Teas Response To Suspension Inquiry Received
May 30, 2013
Attorney/Dom.Rep.Revoked And/Or Appointed
May 30, 2013
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 20, 2013
Automatic Update Of Assignment Of Ownership
Feb 5, 2013
Notification Of Letter Of Suspension E-Mailed
Feb 5, 2013
Letter Of Suspension E-Mailed
Feb 5, 2013
Suspension Letter Written
Feb 4, 2013
Teas/Email Correspondence Entered
Feb 4, 2013
Correspondence Received In Law Office
Feb 4, 2013
Teas Response To Office Action Received
Dec 3, 2012
Notification Of Examiner's Amendment/Priority Action E-Mailed
Dec 3, 2012
Examiner's Amendment/Priority Action E-Mailed
Dec 3, 2012
Combined Examiner's Amendment/Priority Action Automatic Entry
Dec 3, 2012
Examiners Amendment And/Or Priority Action - Completed
Nov 28, 2012
Assigned To Examiner
Nov 15, 2012
Notice Of Design Search Code Mailed
Nov 14, 2012
New Application Office Supplied Data Entered In Tram
Nov 10, 2012
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24